بررسی تغییرات محتوای پروتئینCas3، فیبرونکتین و Col4a1 در پی دو شیوۀ تمرین هوازی و اینتروال همراه با مصرف مکمل آستاگزانتین در بافت قلب رت‌های دیابتی نوع2

1.   Miki T, Yuda S, Kouzu H, Miura T. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart failure reviews. 2013;18(2):149-66.

2.   Huynh K, Kiriazis H, Du X-J, Love JE, Gray SP, Jandeleit-Dahm KA, et al. Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice. Free Radical Biology and Medicine. 2013;60:307-17.

3.   Sari FR, Watanabe K, Thandavarayan RA, Harima M, Zhang S, Muslin AJ, et al. 14-3-3 protein protects against cardiac endoplasmic reticulum stress (ERS) and ERS-initiated apoptosis in experimental diabetes. Journal of pharmacological sciences. 2010;113(4):325-34.

4.   Gao L, Huang K, Jiang D-S, Liu X, Huang D, Li H, et al. Novel role for caspase-activated DNase in the regulation of pathological cardiac hypertrophy. Hypertension. 2015;65(4):871-81.

5.   Byrne NM, Hills AP. The importance of physical activity in the growth and development of children. Children, obesity and exercise Prevention, treatment and management of childhood and adolescent obesity. 2007:50-60.

6.   Chen S, Puthanveetil P, Feng B, Matkovich SJ, Dorn GW, Chakrabarti S. Cardiac miR‐133a overexpression prevents early cardiac fibrosis in diabetes. Journal of cellular and molecular medicine. 2014;18(3):415-21.

7.   Li Y, Zhong Y, Gong W, Gao X, Qi H, Liu K, et al. C-peptide prevents SMAD3 binding to alpha promoters to inhibit collagen type IV synthesis. Journal of molecular endocrinology. 2018;61(1):47-56.

8.   Russo I, Frangogiannis NG. Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities. Journal of molecular and cellular cardiology. 2016;90:84-93.

9.   Marwick TH, Hordern MD, Miller T, Chyun DA, Bertoni AG, Blumenthal RS, et al. Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009;119(25):3244-62.

10. Douairon Lahaye SL, Rannou Bekono F, Broderick T. Physical activity and diabetic cardiomyopathy: myocardial adaptation depending on exercise load. Current Diabetes Reviews. 2014;10(6):371-90.

11. Chengji W, Xianjin F. Exercise protects against diabetic cardiomyopathy by the inhibition of the endoplasmic reticulum stress pathway in rats. Journal of cellular physiology. 2019;234(2):1682-8.

12. Bostick B, Aroor AR, Habibi J, Durante W, Ma L, DeMarco VG, et al. Daily exercise prevents diastolic dysfunction and oxidative stress in a female mouse model of western diet induced obesity by maintaining cardiac heme oxygenase-1 levels. Metabolism. 2017;66:14-22.

13. Kemuriyama T, Tandai-Hiruma M, Kato K, Ohta H, Maruyama S, Sato Y, et al. Endogenous angiotensin II has fewer effects but neuronal nitric oxide synthase has excitatory effects on renal sympathetic nerve activity in salt-sensitive hypertension-induced heart failure. The Journal of Physiological Sciences. 2009;59(4):275-81.

14. Novoa U, Arauna D, Moran M, Nuñez M, Zagmutt S, Saldivia S, et al. High-intensity exercise reduces cardiac fibrosis and hypertrophy but does not restore the nitroso-redox imbalance in diabetic cardiomyopathy. Oxidative medicine and cellular longevity. 2017;2017.

15. Powers SK, Quindry JC, Kavazis AN. Exercise-induced cardioprotection against myocardial ischemia–reperfusion injury. Free Radical Biology and Medicine. 2008;44(2):193-201.

16. Ambati RR, Phang S-M, Ravi S, Aswathanarayana RG. Astaxanthin: sources, extraction, stability, biological activities and its commercial applications—a review. Marine drugs. 2014;12(1):128-52.

17. Park CH, Xu FH, Roh S-S, Song YO, Uebaba K, Noh JS, et al. Astaxanthin and Corni Fructus protect against diabetes-induced oxidative stress, inflammation, and advanced glycation end product in livers of streptozotocin-induced diabetic rats. Journal of Medicinal Food. 2015;18(3):337-44.

18. Li W, Hellsten A, Jacobsson LS, Blomqvist HM, Olsson AG, Yuan X-M. Alpha-tocopherol and astaxanthin decrease macrophage infiltration, apoptosis and vulnerability in atheroma of hyperlipidaemic rabbits. Journal of molecular and cellular cardiology. 2004;37(5):969-78.

19. Alam MN, Hossain MM, Rahman MM, Subhan N, Mamun MAA, Ulla A, et al. Astaxanthin prevented oxidative stress in heart and kidneys of isoproterenol-administered aged rats. Journal of Dietary Supplements. 2018;15(1):42-54.

20. Eizadi M, Ravasi A, Soori R, Baesi K, Choubineh S. Effect of three months aerobic training on TCF7L2 expression in pancreatic tissue in type 2 diabetes rats induced by streptozotocin-nicotinamide. Feyz Journal of Kashan University of Medical Sciences. 2017;21.

21. Fattahi Bafghi A, Homaee HM, Azarbayjani MA. Effects of high intensity interval training and curcumin supplement on antioxidant enzyme in heart tissue of diabetic rats. Iranian Journal of Diabetes and Obesity. 2016;8(3):135-41.

22. Kazemi F, Zahedi Asl S. Atni-inflammation effect of 8-week aerobic training on apelin plasma concentration in diabetic male rats. Iranian Journal of Diabetes and Metabolism. 2017;16(2):85-93.

23. Yeh P-T, Huang H-W, Yang C-M, Yang W-S, Yang C-H. Astaxanthin inhibits expression of retinal oxidative stress and inflammatory mediators in streptozotocin-induced diabetic rats. PLoS One. 2016;11(1):e0146438.

24. SherafatiMoghadam M, Salesi M, Daryanoosh F, HematiNafar M, Fallahi A. The effect of 4 weeks of high intensity interval training on the content of AKT1, mTOR, P70S6K1 and 4E-BP1 in soleus skeletal muscle of rats with type 2 diabetes: An experimental study. Journal of Rafsanjan University of Medical Sciences. 2018;17(9):843-54.

25. Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nature Reviews Cardiology. 2020:1-23.

26. Wang H, Bei Y, Lu Y, Sun W, Liu Q, Wang Y, et al. Exercise prevents cardiac injury and improves mitochondrial biogenesis in advanced diabetic cardiomyopathy with PGC-1α and Akt activation. Cellular physiology and biochemistry. 2015;35(6):2159-68.

27. Zheng J, Cheng J, Zheng S, Zhang L, Guo X, Zhang J, et al. Physical exercise and its protective effects on diabetic cardiomyopathy: what is the evidence? Frontiers in endocrinology. 2018;9:729.

28. Laher I, Beam J, Botta A, Barendregt R, Sulistyoningrum D, Devlin A, et al. Short-term exercise worsens cardiac oxidative stress and fibrosis in 8-month-old db/db mice by depleting cardiac glutathione. Free radical research. 2013;47(1):44-54.

29. da Silva E, Natali AJ, da Silva MF, de Jesus Gomes G, da Cunha DNQ, Toledo MM, et al. Swimming training attenuates the morphological reorganization of the myocardium and local inflammation in the left ventricle of growing rats with untreated experimental diabetes. Pathology-Research and Practice. 2016;212(4):325-34.

30. Qin Q, Feng J, Hu C, Chen X, Qin L, Li Y. Low-intensity aerobic exercise mitigates exercise-induced bronchoconstriction by improving the function of adrenal medullary chromaffin cells in asthmatic rats. The Tohoku journal of experimental medicine. 2014;234(2):99-110.

31. Wang S-Q, Li D, Yuan Y. Long-term moderate intensity exercise alleviates myocardial fibrosis in type 2 diabetic rats via inhibitions of oxidative stress and TGF-β1/Smad pathway. The Journal of Physiological Sciences. 2019;69(6):861-73.

32. Holloway TM, Bloemberg D, da Silva ML, Simpson JA, Quadrilatero J, Spriet LL. High intensity interval and endurance training have opposing effects on markers of heart failure and cardiac remodeling in hypertensive rats. PloS one. 2015;10(3):e0121138.

33. Lockwood CJ, Peters JH. Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia. American journal of obstetrics and gynecology. 1990;162(2):358-62.

34. Alghadir AH, Gabr SA, Al-Eisa E. Cellular fibronectin response to supervised moderate aerobic training in patients with type 2 diabetes. Journal of physical therapy science. 2016;28(4):1092-9.

35. Golbashi R, Gaeini A, Kordi MR, Aboutaleb N, Ghardashi Afousi A. Effect of one period of high-intensity interval training on myocardial collagen-1 and TGF-β1 and cardiac function in post ischemia-reperfusion rats. Daneshvar. 2018;25(135):65-74.

36. Hafstad AD, Lund J, Hadler-Olsen E, Höper AC, Larsen TS, Aasum E. High-and moderate-intensity training normalizes ventricular function and mechanoenergetics in mice with diet-induced obesity. Diabetes. 2013;62(7):2287-94.

37. Akbari N, Azarbayjani MA, Delfan M. Comparison of the effect of 8 weeks of continuous and high intensity interval training on the gene expression of TIMP-2 and MMP-2 in male diabetic rats. Razi Journal of Medical Sciences. 2019;26(10):0-.

38. Samiei A, Behpour N, Tadibi V, Fathi R. Effect of eight weeks of aerobic training on some myocardial fibrosis indices in cardiac muscle of diabetic rats. Annals of Applied Sport Science. 2018;6(4):1-8.

39. Chen K-C, Peng C-C, Hsieh C-L, Peng RY. Exercise ameliorates renal cell apoptosis in chronic kidney disease by intervening in the intrinsic and the extrinsic apoptotic pathways in a rat model. Evidence-Based Complementary and Alternative Medicine. 2013;2013.

40. Habibi P, Alihemmati A, Ahmadiasl N, Fateh A, Anvari E. Exercise training attenuates diabetes-induced cardiac injury through increasing miR-133a and improving pro-apoptosis/anti-apoptosis balance in ovariectomized rats. Iranian Journal of Basic Medical Sciences. 2020;23(1):79-85.

41. Veeranki S, Givvimani S, Kundu S, Metreveli N, Pushpakumar S, Tyagi SC. Moderate intensity exercise prevents diabetic cardiomyopathy associated contractile dysfunction through restoration of mitochondrial function and connexin 43 levels in db/db mice. Journal of molecular and cellular cardiology. 2016;92:163-73.

42. Ghosh S, Khazaei M, Moien-Afshari F, Ang LS, Granville DJ, Verchere C, et al. Moderate exercise attenuates caspase-3 activity, oxidative stress, and inhibits progression of diabetic renal disease in db/db mice. American Journal of Physiology-Renal Physiology. 2009;296(4):F700-F8.

43. Kanter M, Aksu F, Takir M, Kostek O, Kanter B, Oymagil A. Effects of low intensity exercise against apoptosis and oxidative stress in Streptozotocin-induced diabetic rat heart. Experimental and Clinical Endocrinology & Diabetes. 2017;125(09):583-91.

44. Kim DY, Jung SY, Kim CJ, Sung YH, Kim JD. Treadmill exercise ameliorates apoptotic cell death in the retinas of diabetic rats. Molecular medicine reports. 2013;7(6):1745-50.

45. Libonati JR. Cardiac effects of exercise training in hypertension. ISRN Hypertension. 2013;2013.

46. Ji E-S, Ko I-G, Cho J-W, Davis RW, Hwang G-Y, Jee Y-S, et al. Treadmill exercise inhibits apoptotic neuronal cell death with suppressed vascular endothelial growth factor expression in the retinas of the diabetic rats. Journal of exercise rehabilitation. 2013;9(3):348.

47. Polyakov NE, Leshina TV, Konovalova TA, Kispert LD. Carotenoids as scavengers of free radicals in a Fenton reaction: antioxidants or pro-oxidants? Free Radical Biology and Medicine. 2001;31(3):398-404.

48. Focsan AL, Pan S, Kispert LD. Electrochemical study of astaxanthin and astaxanthin n-octanoic monoester and diester: Tendency to form radicals. The Journal of Physical Chemistry B. 2014;118(9):2331-9.

49. Yang M, Zhao T, Deng T, Wang Z. Protective effects of astaxanthin against diabetic retinal vessels and pro-inflammatory cytokine synthesis. Int J Clin Exp Med. 2019;12(5):4725-34.

50. Guo X, Cao J, Wang Y, Zhou H, Zhang J, Niu Y, et al. PL-011 astaxanthin reduces high intensity training induced myocardial cell apoptosis via activating Nrf2 in rats. Exercise Biochemistry Review. 2018;1(1).

51. Xue Y, Sun C, Hao Q, Cheng J. Astaxanthin ameliorates cardiomyocyte apoptosis after coronary microembolization by inhibiting oxidative stress via Nrf2/HO-1 pathway in rats. Naunyn-Schmiedeberg's archives of pharmacology. 2019;392(3):341-8.

52. Hu Y, Shen L, Li L, Li M, Yin W, Liu W, et al. Astaxanthin protects against diabetic cardiomyopathy via activation of Akt pathway in H9c2 cells. Tropical Journal of Pharmaceutical Research. 2018;17(11):2151-6.

53. Li X, Qi Z, Zhao L, Yu Z. Astaxanthin reduces type 2 diabetic‑associated cognitive decline in rats via activation of PI3K/Akt and attenuation of oxidative stress. Molecular medicine reports. 2016;13(1):973-9.

54. Klinkenberg LJ, Res PT, Haenen GR, Bast A, van Loon LJ, van Dieijen-Visser MP, et al. Effect of antioxidant supplementation on exercise-induced cardiac troponin release in cyclists: a randomized trial. PLoS One. 2013;8(11).

55. Yang Y, Kim B, Park Y-K, Koo SI, Lee J-Y. Astaxanthin prevents TGFβ1-induced pro-fibrogenic gene expression by inhibiting Smad3 activation in hepatic stellate cells. Biochimica et Biophysica Acta (BBA)-General Subjects. 2015;1850(1):178-85.

56. Shen M, Chen K, Lu J, Cheng P, Xu L, Dai W, et al. Protective effect of astaxanthin on liver fibrosis through modulation of TGF-1 expression and autophagy. Mediators of inflammation. 2014;2014.

57. Zhu X, Chen Y, Chen Q, Yang H, Xie X. Astaxanthin promotes Nrf2/ARE signaling to alleviate renal fibronectin and collagen IV accumulation in diabetic rats. Journal of diabetes research. 2018;2018.

58. Zhang J, Wang Q-z, Zhao S-h, Ji X, Qiu J, Wang J, et al. Astaxanthin attenuated pressure overload-induced cardiac dysfunction and myocardial fibrosis: Partially by activating SIRT1. Biochimica et Biophysica Acta (BBA)-General Subjects. 2017;1861(7):1715-28.